Parp3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Poly(ADP-Ribose) Polymerase 3 (PARP3) is the third member of the PARP family involved in DNA repair and cell division. While PARP1 and PARP2 are well-characterized, PARP3 has emerged as an important regulator of DNA damage response and genomic stability. [@parp2023]
...
PARP3 — Poly(ADP-Ribose) Polymerase 3
Introduction
Parp3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
Poly(ADP-Ribose) Polymerase 3 (PARP3) is the third member of the PARP family involved in DNA repair and cell division. While PARP1 and PARP2 are well-characterized, PARP3 has emerged as an important regulator of DNA damage response and genomic stability. [@parp2023]
Detectable in brain tissue, particularly in [neurons](/entities/neurons)
Upregulated in response to DNA damage
Disease Associations
Cancer
Overexpressed in various cancers including breast, lung, and colorectal cancer
Associated with poor prognosis in some tumor types
Potential therapeutic target for synthetic lethality approaches
Neurodegeneration
Role in DNA repair deficits in aging brain
May contribute to neurodegenerative disease progression
Potential involvement in Alzheimer's and Parkinson's disease
Research ongoing on PARP3-specific functions in neurons
Therapeutic Targeting
| Approach | Status | Description | |----------|--------|-------------| | PARP3-selective inhibitors | Preclinical | Under development for cancer therapy | | Combination with PARP1/2 inhibitors | Research | Synthetic lethality approaches | | DNA repair enhancement | Research | Neuroprotective strategies |
Gene Regulation
PARP3 expression is regulated at multiple levels:
Transcriptional Regulation: PARP3 expression is induced by DNA damage through p53-dependent mechanisms
Epigenetic Control: The PARP3 promoter contains CpG islands and is subject to [DNA methylation](/entities/dna-methylation)-mediated silencing
Post-Transcriptional Regulation: miRNAs including miR-31-3p target PARP3 mRNA for degradation
Protein Structure
The PARP3 protein (583 amino acids) contains:
N-terminal Domain (1-190): Protein-protein interaction domain with multiple binding partners
Central Domain (191-400): DNA-binding domain with zinc finger motifs
Catalytic Domain (401-583): ADP-ribosyltransferase activity core, shared with PARP1 and PARP2
Evolutionary Conservation
PARP3 is conserved across vertebrates, with orthologs in:
Mus musculus (mouse)
Danio rerio (zebrafish)
Drosophila melanogaster (fruit fly)
Caenorhabditis elegans (nematode)
The conservation of catalytic domain structure suggests fundamental importance in cellular function.
Research Directions
Current research focuses on:
Developing PARP3-selective inhibitors for cancer and neurodegeneration
Understanding tissue-specific functions of PARP3
Investigating PARP3 as a biomarker for DNA damage-related diseases
See Also
[PARP1 Gene](/proteins/parp1-protein) — PARP family member
[PARP2 Gene](/proteins/parp2-protein) — PARP family member
The study of Parp3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[ Ame JC, Spenlehauer C, de Murcia G, The PARP superfamily (2024)](https://doi.org/10.1002/bies.202400156)